» Articles » PMID: 38673807

Cellular Imaging and Time-Domain FLIM Studies of Meso-Tetraphenylporphine Disulfonate As a Photosensitising Agent in 2D and 3D Models

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2024 Apr 27
PMID 38673807
Authors
Affiliations
Soon will be listed here.
Abstract

Fluorescence lifetime imaging (FLIM) and confocal fluorescence studies of a porphyrin-based photosensitiser (meso-tetraphenylporphine disulfonate: TPPS) were evaluated in 2D monolayer cultures and 3D compressed collagen constructs of a human ovarian cancer cell line (HEY). TPPS is known to be an effective model photosensitiser for both Photodynamic Therapy (PDT) and Photochemical Internalisation (PCI). This microspectrofluorimetric study aimed firstly to investigate the uptake and subcellular localisation of TPPS, and evaluate the photo-oxidative mechanism using reactive oxygen species (ROS) and lipid peroxidation probes combined with appropriate ROS scavengers. Light-induced intracellular redistribution of TPPS was observed, consistent with rupture of endolysosomes where the porphyrin localises. Using the same range of light doses, time-lapse confocal imaging permitted observation of PDT-induced generation of ROS in both 2D and 3D cancer models using fluorescence-based ROS together with specific ROS inhibitors. In addition, the use of red light excitation of the photosensitiser to minimise auto-oxidation of the probes was investigated. In the second part of the study, the photophysical properties of TPPS in cells were studied using a time-domain FLIM system with time-correlated single photon counting detection. Owing to the high sensitivity and spatial resolution of this system, we acquired FLIM images that enabled the fluorescence lifetime determination of the porphyrin within the endolysosomal vesicles. Changes in the lifetime dynamics upon prolonged illumination were revealed as the vesicles degraded within the cells.

References
1.
Norum O, Fremstedal A, Weyergang A, Golab J, Berg K . Photochemical delivery of bleomycin induces T-cell activation of importance for curative effect and systemic anti-tumor immunity. J Control Release. 2017; 268:120-127. DOI: 10.1016/j.jconrel.2017.10.015. View

2.
van Straten D, Mashayekhi V, de Bruijn H, Oliveira S, Robinson D . Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions. Cancers (Basel). 2017; 9(2). PMC: 5332942. DOI: 10.3390/cancers9020019. View

3.
Mohammad-Hadi L, MacRobert A, Loizidou M, Yaghini E . Photodynamic therapy in 3D cancer models and the utilisation of nanodelivery systems. Nanoscale. 2018; 10(4):1570-1581. DOI: 10.1039/c7nr07739d. View

4.
cunderlikova B, Bjorklund E, Pettersen E, Moan J . pH-dependent spectral properties of HpIX, TPPS2a, mTHPP and mTHPC. Photochem Photobiol. 2001; 74(2):246-52. DOI: 10.1562/0031-8655(2001)074<0246:pdspoh>2.0.co;2. View

5.
Kessel D, Thompson P, Saatio K, Nantwi K . Tumor localization and photosensitization by sulfonated derivatives of tetraphenylporphine. Photochem Photobiol. 1987; 45(6):787-90. DOI: 10.1111/j.1751-1097.1987.tb07883.x. View